Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients

• Status: Completed
• Trial end date: 2003-08-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will assess an investigational medication for patients with chronic renal insufficiency (pre-dialysis) who have secondary hyperparathyroidism.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Amgen
• Treatments: Cinacalcet; Cinacalcet Hydrochloride

Criteria

Inclusion Criteria:

• Patients must have chronic renal insufficiency (pre-dialysis)

• Have below normal creatinine clearance

• Have elevated parathyroid hormone levels

Exclusion Criteria:

• Pregnant or nursing

• Heart attack in the last 3 months.